Trials
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q3 | 37.2% | 0.892 | Q2 | 80.7% |
| 2024 | 2.0 | Q3 | 36.4% | 0.893 | Q2 | 81.2% |
| 2023 | 2.0 | Q3 | 38.4% | 0.812 | Q2 | 80.2% |
| 2022 | 2.5 | Q3 | 41.9% | 0.814 | Q2 | 81.0% |
| 2021 | 2.7 | Q3 | 51.4% | 0.865 | Q1 | 83.2% |
| 2020 | — | — | 1.067 | Q1 | 86.7% | |
| 2019 | — | — | 0.980 | Q1 | 85.2% | |
| 2018 | — | — | 1.287 | Q1 | 89.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1745-6215
country
coverage
2006-2026
